Glycogen storage disease type III as a model to study glycogen driving tumor development

Glycogen storage disease type III as a model to study glycogen driving tumor development

Glycogen storage disease type III as a model to study glycogen driving tumor development 1125 1625 Metabolism & Cancer
Pseudoprogression as a novel radiological sign of solid tumors underwent sonodynamic therapy
Lipid Metabolism supports the tumorigenic potential of Pancreatic Cancer Stem Cells
The role of adipocyte G0/G1 Switch Gene 2 (G0S2) in the crosstalk between cancer cells and adipocytes
Mitochondrial complex I null cancer models reveal unspecific antiproliferative effects of complex I inhibitors – Copie
Enter your
text here
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.